VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+32.03%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$977M
AUM Growth
+$977M
(+29%)
Cap. Flow
+$9.38M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
75%
Holding
45
New
5
Increased
5
Reduced
6
Closed
3
Top Buys
| 1 |
SVA
Sinovac Biotech, Ltd
SVA
|
$38.2M |
| 2 |
Cidara Therapeutics
CDTX
|
$30.5M |
| 3 |
CytomX Therapeutics
CTMX
|
$13.1M |
| 4 |
Akero Therapeutics
AKRO
|
$12.5M |
| 5 |
Oric Pharmaceuticals
ORIC
|
$10.6M |
Top Sells
| 1 |
Unicycive Therapeutics
UNCY
|
$48.8M |
| 2 |
Soleno Therapeutics
SLNO
|
$41.9M |
| 3 |
Bolt Biotherapeutics
BOLT
|
$18.7M |
| 4 |
Instil Bio
TIL
|
$6.1M |
| 5 |
RGLS
Regulus Therapeutics
RGLS
|
$4.72M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$3.6B
| $332M | 33.94% | 3,958,294 -500,000 | -11% | -$41.9M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $132M | 13.49% | 1,393,432 -45,353 | -3% | -$4.29M |
|
|
3
Cidara Therapeutics
CDTX
$1.66B
| $63.9M | 6.54% | 1,311,425 +627,149 | +92% | +$30.5M |
|
4
Geron
GERN
$893M
| $38.4M | 3.93% | 27,225,292 | – | – |
|
|
SVA
5
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 3.91% | +5,903,000 | New | +$38.2M |
|
|
6
Oric Pharmaceuticals
ORIC
$994M
| $31.7M | 3.25% | 3,126,604 +1,046,154 | +50% | +$10.6M |
|
7
Terns Pharmaceuticals
TERN
$609M
| $25.7M | 2.63% | 6,895,746 | – | – |
|
8
Trevi Therapeutics
TRVI
$883M
| $24.5M | 2.51% | 4,487,903 +1,000,000 | +29% | +$5.47M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $23.8M | 2.43% | 2,684,109 | – | – |
|
|
10
Akero Therapeutics
AKRO
$3.74B
| $23.2M | 2.37% | 434,689 +233,521 | +116% | +$12.5M |
|
11
Compass Therapeutics
CMPX
$483M
| $15.7M | 1.61% | 6,043,466 +2,487,443 | +70% | +$6.47M |
|
12
Viridian Therapeutics
VRDN
$1.5B
| $13.7M | 1.41% | 982,576 | – | – |
|
|
13
CytomX Therapeutics
CTMX
$336M
| $13.1M | 1.34% | +5,769,230 | New | +$13.1M |
|
14
Aclaris Therapeutics
ACRS
$209M
| $12.6M | 1.29% | 8,888,888 | – | – |
|
|
ZBIO
15
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $11.5M | 1.17% | 1,183,260 | – | – |
|
16
Dyne Therapeutics
DYN
$1.92B
| $10.6M | 1.09% | 1,114,960 | – | – |
|
17
Abeona Therapeutics
ABEO
$350M
| $10.5M | 1.07% | 1,842,751 | – | – |
|
|
DBVT
18
DBV Technologies
DBVT
$264M
| $9.66M | 0.99% | +1,054,506 | New | +$9.66M |
|
19
Tourmaline Bio
TRML
$601M
| $9.46M | 0.97% | 591,882 | – | – |
|
20
Rezolute
RZLT
$619M
| $9.42M | 0.96% | 2,112,432 | – | – |
|
|
CMPS
21
Compass Pathways
CMPS
$424M
| $9.41M | 0.96% | 3,362,385 | – | – |
|
22
Corvus Pharmaceuticals
CRVS
$428M
| $8.94M | 0.91% | 2,234,566 | – | – |
|
23
Erasca
ERAS
$445M
| $8.58M | 0.88% | 6,756,756 | – | – |
|
24
IO Biotech
IOBT
$104M
| $8.58M | 0.88% | 6,173,439 | – | – |
|
25
Astria Therapeutics
ATXS
$349M
| $8.32M | 0.85% | 1,552,685 | – | – |
|